Tag: Full-cycle Production

NEARMEDIC launched the first Russian facility for DNA testing reagents production

The full-cycle facility is to manufacture reactants for genetic person’s identification and establishment of filiation through DNA tests.

Binnopharm production facilities acquired the status of industrial complex

This will allow the company to receive tax preferences and other benefits, including reduced rates of profit tax, preferential rate of land lease and others.

“Percentage” preferences will provide incentives to localize manufacturing

Rachik Petrosyan, the Deputy Head of the Russian Antimonopoly Service (FAS), said that his agency views the presence of foreign suppliers as a tremendous benefit for the Russian market

MSD and Akrikhin co-invest 300 million rubles in innovative medicines production

Companies aim to expand and deepen partnership in the transfer of pharmaceutical technologies MSD, a global healthcare company known as Merck & Co., Inc. in the U.S. and Canada, and the leading...